Clinical performance of hemodynamics-based non-invasive device for skin cancer testing
Ended Project Grant Awarded Last action
- Award ID
- R44CA250768
- Recipient
-
Veriskin, Inc. UEI M9MBEBYMQ1N3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,665,355
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $2,831,895.00 Federal
- $833,460.00 Non-federal
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $833,460 | $0 | |
| Amendment | $833,460 | $833,460 | |
| Original award | $1,164,975 | $0 |
Quick answers
Who received award R44CA250768?
R44CA250768 was awarded to Veriskin, Inc. by National Cancer Institute (National Institutes of Health) on March 15, 2020.
How much is award R44CA250768 worth?
$3,665,355 has been obligated on R44CA250768: $2,831,895 in federal funding and $833,460 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award